We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWSS
1901
DELISTED
Clean Energy Special Situations Corp. Common stock
SWSS
$1.2M 0.01%
+246,028
New +$1.2M
FORR icon
1902
Forrester Research
FORR
$200M
$1.2M 0.01%
+24,386
New +$1.14M
PBR icon
1903
Petrobras
PBR
$116B
$1.2M 0.01%
116,188
-789,896
-87% -$8.41M
EDTX
1904
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$1.2M 0.01%
+120,299
New +$1.2M
MASS icon
1905
908 Devices
MASS
$288M
$1.2M 0.01%
36,835
+31,614
+606% +$1.07M
CTV
1906
DELISTED
Innovid Corp.
CTV
$1.19M 0.01%
120,514
+20,554
+21% +$203K
CFIV
1907
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$1.19M 0.01%
+122,730
New +$1.19M
BARK.WS
1908
CALL
DELISTED
BARK Inc Warrants
BARK.WS
$1.19M ﹤0.01%
173,136
+14,360
+9% +$31.2K
INFY icon
1909
Infosys
INFY
$50B
$1.19M ﹤0.01%
53,452
+2,840
+6% +$64.2K
WPCA.WS
1910
CALL
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$1.18M ﹤0.01%
120,420
SRTA
1911
Strata Critical Medical Inc
SRTA
$440M
$1.18M ﹤0.01%
113,237
+3,070
+3% +$26.8K
LITE icon
1912
Lumentum
LITE
$50.7B
$1.18M ﹤0.01%
14,090
+8,994
+176% +$754K
OPRA
1913
Opera Ltd
OPRA
$1.71B
$1.18M ﹤0.01%
132,969
-62,611
-32% -$609K
TEAM icon
1914
Atlassian
TEAM
$25.4B
$1.17M ﹤0.01%
3,000
-2,087
-41% -$697K
GETR.WS
1915
CALL
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.17M ﹤0.01%
119,992
CWH icon
1916
Camping World
CWH
$399M
$1.17M ﹤0.01%
+30,178
New +$1.19M
CPARW
1917
CALL
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$1.17M ﹤0.01%
+119,995
New +$144K
CCU icon
1918
Compañía de Cervecerías Unidas
CCU
$2.2B
$1.17M ﹤0.01%
67,499
-116,408
-63% -$2.31M
MRNA icon
1919
Moderna
MRNA
$22.1B
$1.16M ﹤0.01%
3,022
+338
+13% +$125K
UAL icon
1920
PUT
United Airlines
UAL
$40.2B
$1.16M ﹤0.01%
24,400
+22,600
+1,256% +$1.06M
NNBR icon
1921
NN Inc
NNBR
$261M
$1.16M ﹤0.01%
220,959
+38,257
+21% +$230K
QUAD icon
1922
Quad
QUAD
$434M
$1.16M ﹤0.01%
272,724
-112,268
-29% -$464K
EQRXW
1923
CALL
DELISTED
EQRx, Inc. Warrant
EQRXW
$1.15M ﹤0.01%
116,366
+76,371
+191% +$166K
GRDI
1924
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$1.15M ﹤0.01%
+117,692
New +$1.14M
NTST
1925
NETSTREIT Corp
NTST
$2.13B
$1.14M ﹤0.01%
+48,099
New +$1.21M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.